Osiris Therapeutics Inc. (OSIR) News Nov 20, 2014, 5:14

New Post Public Reply Private Reply Replies (0) Message Board

Nov 21, 2014 at 3:18 AM

Osiris Therapeutics Inc. (OSIR) News Nov 20, 2014, 5:14 p.m.
MarketWatch News on OSIR
Small biopharma Osiris jumps after reporting an unexpected profit 11:23 a.m. March 5, 2014 - Russ Britt
Earnings, deals aid medical supplier, biopharmas on mixed market day 10:32 a.m. Oct. 11, 2013 - Russ Britt
Six stocks with continuing upside 1:50 p.m. Aug. 14, 2013 - The Trading Deck
Osiris keeps losses down, investors reward shares 7:34 p.m. March 6, 2013 - Russ Britt
Osiris Therapeutics down 5% in premarket trades 7:25 a.m. July 3, 2012 - Steve Gelsi
Thursday’s biggest gaining and declining stocks 3:56 p.m. June 21, 2012 - MarketWatch
Monday’s biggest gaining and declining stocks 3:24 p.m. June 18, 2012 - MarketWatch
Osiris gains on New Zealand regulatory approval 11:57 a.m. June 18, 2012 - Val Brickates Kennedy
Osiris: Gov't OKs pass-through status for Grafix 5:44 p.m. May 29, 2012 - MarketWatch.com
Osiris shares rally for second straight session 1:10 p.m. May 21, 2012 - Val Brickates Kennedy
Stocks to watch Friday: Osiris, Autodesk, Marvell 5:49 a.m. May 18, 2012 - MarketWatch
Osiris stem-cell therapy wins Canadian approval 4:43 p.m. May 17, 2012 - Val Brickates Kennedy
Osiris up 14% after Canada OKs stem-cell treatment 4:33 p.m. May 17, 2012 - Carla Mozee
Court upholds stem-cell research funding: reports 10:46 a.m. July 27, 2011 - Val Brickates Kennedy
Are stem-cell stocks a good buy? 2:06 p.m. July 13, 2011 - Val Brickates Kennedy
Stem-cell stocks rise on artificial-trachea report 1:57 p.m. July 8, 2011 - Val Brickates Kennedy
Radiation drug makers lose some ground 11:31 a.m. March 16, 2011 - Russ Britt
Appeals court blocks stem-cell funding ban: AP 2:51 p.m. Sept. 9, 2010 - Val Brickates Kennedy
Stem-cell stocks regain ground 3:13 p.m. Aug. 26, 2010 - Val Brickates Kennedy
Drug stocks trend higher in afternoon action 11:59 a.m. June 24, 2009 - Val Brickates Kennedy

Other News on OSIR
Osiris Therapeutics, Inc. (OSIR): New Analyst Report from Zacks Equity Research - Zacks Equity Research Report 7:00 a.m. Nov. 12, 2014 - Zacks.com
Osiris Therapeutics, Inc. (OSIR): New Analyst Report from Zacks Equity Research - Zacks Equity Research Report 7:00 a.m. Nov. 12, 2014 - Zacks.com
Osiris Therapeutics Beats on Q3 Earnings & Revenues - Analyst Blog 9:00 a.m. Nov. 11, 2014 - Zacks.com
10-Q: OSIRIS THERAPEUTICS, INC. 10:35 a.m. Nov. 10, 2014 - Edgar Online - (EDG = 10Q, 10K)
Osiris Therapeutics' (OSIR) CEO Lode Debrabandere on Q3 2014 Results - Earnings Call Transcript 12:00 p.m. Nov. 7, 2014 - Seeking Alpha
Osiris Therapeutics (OSIR) Q3 2014 Results - Earnings Call Webcast 8:55 a.m. Nov. 7, 2014 - Seeking Alpha
Japan Gives A Hug To The Cell Therapy Industry: R. Lee Buckler 7:21 a.m. Oct. 24, 2014 - Seeking Alpha
Avita Medical: A Comprehensive Look At An Unknown Company With A Transcendent Technology 12:35 p.m. Oct. 7, 2014 - Seeking Alpha
Update: Osiris Therapeutics Earnings 7:55 a.m. Aug. 15, 2014 - Seeking Alpha
Osiris Falls despite Narrower Q2 Loss and Higher Revenues - Analyst Blog 10:50 a.m. Aug. 11, 2014 - Zacks.com
10-Q: OSIRIS THERAPEUTICS, INC. 5:11 a.m. Aug. 11, 2014 - Edgar Online - (EDG = 10Q, 10K)
Osiris Therapeutics (OSIR) Q1 2014 Results - Earnings Call Webcast 7:55 a.m. Aug. 7, 2014 - Seeking Alpha
Osiris Stem Cells To Compliment Mannkind's Afrezza In Disrupting Diabetes Market 3:50 p.m. July 29, 2014 - GuruFocus.com
Arena Pharmaceuticals-Eisai Boost Obesity Drug Sales Force - Analyst Blog 3:45 p.m. July 11, 2014 - Zacks.com
Osiris Therapeutics' Survival In Doubt After Losing 'Pass-Through' Status In 2015 10:56 a.m. July 11, 2014 - Seeking Alpha
Lexicon (LXRX) Jumps: Stock Moves 7.6% Higher - Tale of the Tape 8:46 a.m. July 10, 2014 - Zacks.com
BIND Therapeutics (BIND) in Focus: Stock Tumbles 10.0% - Tale of the Tape 7:44 a.m. July 7, 2014 - Zacks.com
Merge Healthcare: Updated Research Report - Analyst Blog 1:55 p.m. June 20, 2014 - Zacks.com
Illumina: Updated Research Report - Analyst Blog 1:30 p.m. June 20, 2014 - Zacks.com
Geron Gains as FDA Lifts Partial Hold on Imetelstat Study - Analyst Blog 12:10 p.m. June 13, 2014 - Zacks.com

Press Releases on OSIR
Osiris Therapeutics to Present at the Canaccord Genuity Medical Technology and Diagnostics Forum 8:04 a.m. Nov. 17, 2014 - BusinessWire - BZX
Osiris Therapeutics Announces Third Quarter 2014 Financial Results: Revenue up 29% and Company Turned Profitable 8:02 a.m. Nov. 7, 2014 - BusinessWire - BZX
Reckitt Benckiser Pharmaceuticals Inc. Announces Appointment of Chief Financial Officer 8:00 a.m. Nov. 4, 2014 - PR Newswire - PRF
Osiris and Arthrex announce an exclusive partnership for the commercialization and development of Cartiform® 7:01 a.m. Oct. 17, 2014 - BusinessWire - BZX
Osiris to present three studies on benefits of cryopreserved placental membranes for chronic wounds 7:02 a.m. Oct. 16, 2014 - BusinessWire - BZX
Analysis of the Global Stem Cell Market 2:14 p.m. Oct. 13, 2014 - PR Newswire - PRF
Osiris Therapeutics Announces Third Quarter 2014 Financial Results Conference Call 10:58 a.m. Oct. 13, 2014 - BusinessWire - BZX
Osiris Therapeutics to Present at the 2014 Stem Cell Meeting on the Mesa 7:01 a.m. Sept. 25, 2014 - BusinessWire - BZX
Grafix® Featured in Plenary Session Oral Presentation at the Joint Annual Meeting of the Eastern and New England Vascular Societies 3:16 p.m. Sept. 15, 2014 - BusinessWire - BZX
Grafix® Randomized Controlled Clinical Trial Recognized as High Quality DFU Trial in Recent Wounds Supplement 8:02 a.m. Sept. 11, 2014 - BusinessWire - BZX
EQUITY ALERT: Rosen Law Firm Announces Investigation of Securities Claims Against Osiris Therapeutics, Inc. -- OSIR 9:37 a.m. Aug. 14, 2014 - BusinessWire - BZX
Osiris Therapeutics Announces Second Quarter 2014 Financial Results: Revenue Up 32% Over Previous Quarter 7:04 a.m. Aug. 7, 2014 - BusinessWire - BZX
Grafix® Manuscript from Osiris’ Multi-center, Randomized, Controlled Clinical Trial Available Electronically in Peer-Reviewed Journal 3:00 p.m. July 22, 2014 - BusinessWire - BZX
Osiris Therapeutics Announces Second Quarter 2014 Financial Results Conference Call 3:00 p.m. July 14, 2014 - BusinessWire - BZX
Osiris Therapeutics to Present at the 9th Annual JMP Securities Healthcare Conference 7:00 a.m. June 20, 2014 - BusinessWire - BZX
Grafix® Manuscript from Osiris’ Multi-center, Randomized, Controlled Clinical Trial Accepted in Peer-Reviewed Journal 7:02 a.m. June 19, 2014 - BusinessWire - BZX
Osiris Therapeutics to Present at the Jefferies 2014 Global Healthcare Conference 7:01 a.m. May 30, 2014 - BusinessWire - BZX
Business Highlights, Financial Results, and Leadership Appointments - Analyst Notes on PDL BioPharma, bluebird, Osiris, Agios and Ophthotech 6:00 a.m. May 19, 2014 - PR Newswire - PRF
MediPoint: Bone Grafts and Substitutes - Global Analysis and Market Forecasts 11:33 a.m. May 14, 2014 - PR Newswire - PRF
Osiris Reports First Quarter 2014 Results: Revenue Up 25% and Gross Margin Improved from 73% to 78% 3:01 p.m. May 12, 2014 - BusinessWire - BZX

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Countries Eye New Investment Paths at CIFIT 2026

Global Investment Winds Shift at CIFIT In the thick of a world that's being turned on its head, you've got big shots from 129 countries and 30 international organizations talking shop at the 26th China International Fair for Investment and Trade (CIFIT) in Xiamen. Take your pick from the 48 of the world's top 50 GDP powerhouses rubbing shoulders there—this ain't your...

Larry Ellison's Moves Signal Confidence in Oracle's Future

Unraveling Ellison's Bold Decision There's nothing like a sudden shift from a tech titan to make Wall Street sit up and take notice. Today, we got the word that Larry Ellison, Oracle's big gun as Executive Chair and CTO, has pulled the plug on his plan to sell Oracle stock. No dice, no distance covered under that plan. And he's made it crystal clear—selling isn't on his...

ARTiSTORY's Strategic Advance in Cultural IP Licensing

Call it a seismic shift or call it common sense, but ARTiSTORY's recent haul of accolades makes it clear: they're onto something big in the cultural IP game. Receiving four honors at the 26th International Advertising Institute Awards (IAI Awards), including a Gold for their British Library × CHAGEE collaboration, and jumping into License Global's Top 60, they're staking...

New 2027 Jeep Wrangler JL-2A: A Blast from the Past

Revisiting a Prized Legacy: The 2027 Jeep Wrangler JL-2A Sometimes, what’s new is really just a nod to what’s old—and nowhere is this more so than with the 2027 Jeep Wrangler JL-2A. In the grand parade of automotive history, Jeep's latest creation is more than just a vehicle; it's a time machine that cruises on its historic lineage while strapping on all the modern...

Damp or Dry: The Battle for Healthy Air in Colorado

The Hidden Cost of Colorado's Dry Air Dry climate isn't just a seasonal inconvenience—it's a real hidden cost to living comfortably and healthily in Colorado. With winters colder than a brass monkey's tail and summers that don't offer much relief in terms of humidity, your home's air quality is on the front line. So, what's the financial tale here, and how do you come...

OneOdio Showcases Innovation at IFA 2026 in Berlin

Echoes from Berlin IFA 2026 in Berlin was a cacophony of innovation, as OneOdio wrapped up its showcase with a bang. Boasting interactive activities and live DJ sets, the event echoed OneOdio's drive to meld advanced audio technology with the pulsating needs of music pros and everyday listeners. You couldn’t miss the excitement in the air at Booth 217. Tech Unplugged:...

U.S. Green Beret's Mission: Clearing Landmines in Ukraine

The Rise of "Safe Ground" on Prime Video This isn't your typical feel-good story—it’s about grit and the unending fight for 'normalcy' where war left scars. Safe Ground, now streaming on Prime Video, showcases Ryan Hendrickson, a U.S. Army Green Beret whose story takes a sharp turn after stepping on an IED in 2010. The day he almost became just another statistic...

SMPL Faces Legal Drama: What Investors Need to Know

Investors Swim Against the Current With SMPL Picture this: You’re sipping your morning coffee, glancing through stocks, only to choke on your bagel when The Simply Good Foods Company (NASDAQ: SMPL) pops up with some less-than-palatable news. A class action is brewing, shouting out to investors who took the bait from October 24, 2024, to April 8, 2026. If you’re one of...

PathoSearch: A New Era in Pathology With Visual Search

Revolutionizing Pathology with a Visual Search Engine In an era where time is money and precision is paramount, Aignostics is betting big on transforming the pathology landscape. Today, their announcement of PathoSearch, a visual search engine designed for retrieving comparable diagnosed pathology cases, marks a massive leap towards streamlining the diagnostic process....

D-Wave Faces Legal Questions After CFO Exit and Losses

Trouble Brews at D-Wave Quantum Smack in the middle of market chaos, D-Wave Quantum Inc. (NASDAQ: QBTS) seems to have hit a rather gnarly pothole. With disappointing revenue figures for Q2 of 2026—coming in at a measly $3.08 million, far below the expected range of $4.03 million to $4.08 million—investors have more than enough reasons to be irked. When the numbers...